Ten VC combines partners with 15+ years of cross-over experience in both traditional VC and corporate venture (like LEO Pharma Corporate VC) with a thesis focused on breakthrough applications of deep science, industrial new normal, and new infrastructure & tools across deeptech/biotech, advanced manufacturing, and critical infrastructure. The fund operates with four structured networks—Scouting Teams, Industry Leaders, Functional Experts, and Technology Specialists—and commits to reviewing every pitch deck sent while spanning the U.S., Europe, Canada, and Israel with explicit focus on research labs in their scouting network.